-

$undefined

N/A

(N/A)

GRI Bio Inc. :GRI

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-3.952M

Cash

6.353M

Avg Qtr Burn

-2.804M

Short % of Float

34.85%

Insider Ownership

0.35%

Institutional Own.

4.71%

Qtr Updated

06/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ADAIR (proprietary abuse-deterrent formulation of immediate-release) Details Attention deficit hyperactivity disorder	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GRI-0621 Details Idiopathic pulmonary fibrosis, Lung disease	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GRI-0803 Details Autoimmune disease, Systemic lupus erythematosus	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.